phosphorylation drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (6)
Papers in which this entity is mentioned.
- RNA splicing dysregulation and the hallmarks of cancer. (2023)
- Most non-canonical proteins uniquely populate the proteome or immunopeptidome. (2021)
- Best practices for bioinformatic characterization of neoantigens for clinical utility. (2019)
- Comprehensive Characterization of Cancer Driver Genes and Mutations. (2018)
- Epigenetics studies of fetal alcohol spectrum disorder: where are we now? (2017)
- Involvement of p53 in the repair of DNA double strand breaks: multifaceted Roles of p53 in homologous recombination repair (HRR) and non-homologous end joining (NHEJ). (2014)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| phosphorylation | drug | 20 | 26 |